Sector--
Established Date26/05/2011
Listing Date02/06/2016
ExchangeNASDAQ Stock Exchange
Full-time Employees32
Fiscal Year Ends31/12
Security TypeCommon stock
Office address900 North Point Parkway, Suite 200, Alpharetta, GA 30005
Business
IntroductionClearside Biomedical, Inc., was incorporated in Delaware on May 26, 2011. The company is a late-stage clinical biopharmaceutical company that develops first-in drug therapies to treat blinding diseases of the eye. The company's current product candidates focus on addressing diseases affecting the retina and choroid, especially macular edema, and are injected into the suprachoroidal space using its proprietary SCS microinjector.
